Hyaluronan as a therapeutic target in human diseases
Accumulation and turnover of extracellular matrix is a hallmark of tissue injury, repair and
remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix …
remodeling in human diseases. Hyaluronan is a major component of the extracellular matrix …
Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment
Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal condition that causes severe
scarring of the lungs. While the pathogenesis of IPF continues to be extensively studied and …
scarring of the lungs. While the pathogenesis of IPF continues to be extensively studied and …
Arthropod venom Hyaluronidases: biochemical properties and potential applications in medicine and biotechnology
KCF Bordon, GA Wiezel, FG Amorim… - Journal of venomous …, 2015 - SciELO Brasil
Hyaluronidases are enzymes that mainly degrade hyaluronan, the major glycosaminoglycan
of the interstitial matrix. They are involved in several pathological and physiological activities …
of the interstitial matrix. They are involved in several pathological and physiological activities …
Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases
Delivering drugs through inhalation for systemic and local applications has been in practice
since several decades to treat various diseases. In recent times, inhalation drug delivery is …
since several decades to treat various diseases. In recent times, inhalation drug delivery is …
A fractional factorial design to study the effect of process variables on the preparation of hyaluronidase loaded PLGA nanoparticles
K Narayanan, VM Subrahmanyam… - Enzyme …, 2014 - Wiley Online Library
The present study was initiated to understand the effect of PLGA concentration, PVA
concentration, internal‐external phase ratio, homogenization speed, and homogenization …
concentration, internal‐external phase ratio, homogenization speed, and homogenization …
Towards toxin PEGylation: The example of rCollinein-1, a snake venom thrombin-like enzyme, as a PEGylated biopharmaceutical prototype
EL Pinheiro-Junior, J Boldrini-França… - International Journal of …, 2021 - Elsevier
PEGylation was firstly described around 50 years ago and has been used for more than 30
years as a strategy to improve the drugability of biopharmaceuticals. However, it remains …
years as a strategy to improve the drugability of biopharmaceuticals. However, it remains …
Naja annulifera Snake: New insights into the venom components and pathogenesis of envenomation
F Silva-de-Franca, IM Villas-Boas… - PLoS Neglected …, 2019 - journals.plos.org
Background Naja annulifera is a medically important venomous snake occurring in some of
the countries in Sub-Saharan Africa. Accidental bites result in severe coagulation …
the countries in Sub-Saharan Africa. Accidental bites result in severe coagulation …
Immunomodulatory activity of hyaluronidase is associated with metabolic adaptations during acute inflammation
Objective and design Investigate survival outcomes, and immunological and metabolomic
effects of hyaluronidase (Hz) treatment during mouse models of acute inflammation and …
effects of hyaluronidase (Hz) treatment during mouse models of acute inflammation and …
Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes
S Ohta, M Matsuura, Y Kawashima, X Cai… - Colloids and Surfaces B …, 2019 - Elsevier
We developed a facile fabrication method for preparing poly (ethylene glycol)(PEG)-coated
poly (lactic-co-glycolic acid)(PLGA) microspheres with homogeneous size distribution via a …
poly (lactic-co-glycolic acid)(PLGA) microspheres with homogeneous size distribution via a …
HYAL1 is downregulated in idiopathic pulmonary fibrosis and inhibits HFL‐1 fibroblast proliferation when upregulated
D Leng, X Huang, J Yi, H Zhao… - BioMed research …, 2020 - Wiley Online Library
Background. Idiopathic pulmonary fibrosis (IPF), the most common interstitial lung disease,
arises from transforming growth factor beta 1‐(TGFβ1‐) induced aberrant fibroproliferation in …
arises from transforming growth factor beta 1‐(TGFβ1‐) induced aberrant fibroproliferation in …